Search
Alnylam Pharmaceuticals Inc
ALNYAdd to Watchlist
248.680USD
+1.170+0.47%
Close 09-11 16:00（ET）
33.25BMarket Cap
60.86P/E TTM
After-hours 18:41 (ET)250.000USD+1.170+0.47%
After-hours 18:41 (ET)Alnylam Pharmaceuticals Inc (ALNY) Revenue Performance
Updated: Jun 30, 2026Last year, Alnylam Pharmaceuticals Inc generated 2.31B USD for its biggest-performing segment, AMVUTTRA. The United States made the largest contribution, accounting for 2.07B USD last year. For the latest quarter, Alnylam Pharmaceuticals Inc reported the revenue of 1.01B USD for the period ending 2026-06-30, which came from the top-performing segment, AMVUTTRA. United States contributed the highest revenue, at 895.49M USD.
By Business
Revenue
Proportion
Annual
Annual
Quarterly
AMVUTTRA
Roche
GIVLAARI
Other
OXLUMO
ONPATTRO
Regeneron Pharmaceuticals
Novartis AG
Vir Biotechnology
FY2025
FY2024
FY2023
FY2022
FY2021
AMVUTTRA
2.31B(62.30%)
970.45M(43.16%)
557.84M(30.51%)
93.80M(9.04%)
--(--)
Roche
394.88M(10.63%)
119.49M(5.31%)
--(--)
--(--)
--(--)
GIVLAARI
308.49M(8.31%)
255.87M(11.38%)
219.25M(11.99%)
173.14M(16.69%)
127.81M(15.14%)
Other
218.55M(5.88%)
99.97M(4.45%)
399.62M(21.86%)
10.33M(1.00%)
2.91M(0.34%)
OXLUMO
191.44M(5.15%)
167.05M(7.43%)
109.84M(6.01%)
69.78M(6.73%)
59.59M(7.06%)
ONPATTRO
172.79M(4.65%)
252.86M(11.25%)
354.55M(19.39%)
557.61M(53.75%)
474.74M(56.23%)
Regeneron Pharmaceuticals
113.96M(3.07%)
302.80M(13.47%)
100.47M(5.50%)
87.84M(8.47%)
113.23M(13.41%)
Novartis AG
--(--)
79.76M(3.55%)
86.73M(4.74%)
43.16M(4.16%)
49.12M(5.82%)
Vir Biotechnology
--(--)
--(--)
--(--)
1.75M(0.17%)
16.90M(2.00%)
By Region
Revenue
Proportion
Annual
Annual
Quarterly
United States
Europe
Net revenues from collaborations
Rest of World
Royalty revenue
Rest of World
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
United States
2.07B(55.67%)
933.54M(41.52%)
689.02M(37.69%)
615.72M(59.35%)
506.98M(60.05%)
325.70M(66.09%)
Europe
651.09M(17.53%)
516.30M(22.96%)
399.34M(21.84%)
314.86M(30.35%)
260.28M(30.83%)
120.09M(24.37%)
Net revenues from collaborations
553.37M(14.90%)
510.22M(22.69%)
546.18M(29.87%)
--(--)
--(--)
--(--)
Rest of World
267.93M(7.21%)
--(--)
--(--)
--(--)
--(--)
--(--)
Royalty revenue
174.02M(4.69%)
91.79M(4.08%)
40.63M(2.22%)
--(--)
--(--)
--(--)
Rest of World
--(--)
196.39M(8.74%)
153.12M(8.37%)
106.84M(10.30%)
77.03M(9.12%)
47.06M(9.55%)